Home - Products - Polypeptide
Mobile/Wechat/WhatsApp: +852 61915425
Email:niki@healthtide-api.com
CasNo: 61912-98-9
Definition | HUMAN LONG R3IGF-I, also known as Long R3 IGF-I, is a recombinant analog of insulin-like growth factor (IGF) that contains the complete human IGF-I amino acid sequence with a substitution of Arg for Glu3. This modification enhances its stability and potency. |
Purpose and Engineering | Specifically engineered for use in biopharmaceutical protein production in mammalian cells. |
Growth Support | Capable of supporting the growth and survival of Chinese hamster ovary cells in serum-free media. Demonstrates potency at concentrations at least 200-fold lower than required for insulin. |
Potency in Cell Culture | Acts as a more potent growth and survival factor than insulin or native IGF-I in the serum-free culture of human embryonic kidney (HEK293) cells. |
Structural Features | Recombinant human insulin-like growth factor (IGF). Consists of 83 amino acids with a 13 amino acid extension peptide at the N-terminus. |
Uses | Long R3 IGF-I is specifically designed for use in mammalian serum-free cell culture to promote cell growth and survival. It has a prolonged half-life compared to native IGF-I, making it more effective in stimulating cellular proliferation and survival in vitro. |
The affinity of LR3 to IGFBPs measured by competition assays and Western ligand blots is at least 3 orders of magnitude lower than that of IGF-I. LR3 was most efficient in stimulating early embryonic cleavage, whereas further development was most potently supported by IGF-I.
Previous work in rhesus monkeys has shown that both acute or chronic subcutaneous (s.c.) administration of insulin-like growth factor (IGF)-I elevates serum concentrations of IGF binding protein (IGFBP)-3. In order to determine whether an analog of IGF-I, which has a reduced affinity for the IGFBPs, has similar effects, a series of studies using adolescent female rhesus monkeys were conducted.